MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Activity
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

27 hedge funds and large institutions have $73.2M invested in Marinus Pharmaceuticals, Inc in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+6
Holders Change %
+28.57%
% of All Funds
0.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
5
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$2.73M
2
ACH
2
ArrowMark Colorado Holdings
Colorado
$2.47M
3
NLVP
3
New Leaf Venture Partners
New York
$7.58M
4
Goldman Sachs
4
Goldman Sachs
New York
$1.23M
5
SFM
5
Sphera Funds Management
Israel
$3.46M

Top Sellers

1
EA
1
Emerald Advisers
Pennsylvania
$2.15M
2
AIC
2
AWM Investment Company
New York
$1.62M
3
EMFAT
3
Emerald Mutual Fund Advisers Trust
Pennsylvania
$0
4
ACP
4
Acuta Capital Partners
California
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$192K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$1K +$1K +14 New
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
EMFAT
28
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$1.42M -40,726 Closed
ACP
29
Acuta Capital Partners
California
– -$325K -9,027 Closed
SIM
30
Spark Investment Management
New York
– -$148K -4,175 Closed
WMSA
31
Weiss Multi-Strategy Advisers
New York
– -$90K -2,500 Closed
BIT
32
BlackRock Institutional Trust
California
– -$14K -397 Closed
TRCT
33
Tower Research Capital (TRC)
New York
– -$3K -75 Closed
1
2